Article courtesy of PMLive
13 market-changing drugs expected to hit the European market this year, many of which are set to achieve blockbuster status due to expectations of having a significant impact on treating certain cancers, epilepsy, rheumatoid arthritis, peanut allergies, multiple sclerosis and other conditions.
These projected blockbusters reflect the continued innovation within the pharmaceutical industry.
Read the full list of drug launches for 2019 here